BREAKING

Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 8 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 8 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 9 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 10 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 10 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 11 hours ago Atmus Welcomes Heath Sharp to Board of Directors 13 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 13 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 8 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 8 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 9 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 10 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 10 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 11 hours ago Atmus Welcomes Heath Sharp to Board of Directors 13 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 13 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago

ADVERTISEMENT

AlphaGraphs

Key highlights from AngioDynamics (ANGO) Q4 2020 earnings results

AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020. Net loss for the fourth quarter was $156 million, or $4.10 per share, compared to net loss of $165.8 million, or $4.37 per share in the fourth quarter of 2019 Net sales decreased 41% to $58.3 million […]

$ANGO July 16, 2020 1 min read

AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020.

Net loss for the fourth quarter was $156 million, or $4.10 per share, compared to net loss of $165.8 million, or $4.37 per share in the fourth quarter of 2019
Net sales decreased 41% to $58.3 million
Capital expenditures during the quarter was $1.5 million

Looking forward to listening to management/analysts comments on Q4 results? Stay tuned here for AngioDynamics Q4 2020 earnings call transcript

AngioDynamics Reports Fiscal 2020 Fourth Quarter and Full-Year Financial Results

ADVERTISEMENT